SlideShare una empresa de Scribd logo
1 de 34
Neurotransmission
Brian J. Piper, Ph.D., M.S.
Goals
• Introduction to neurocommunication
• Families of receptors (2)
• Inactivation of neurotransmission (3)
Otto Loewi
• Discovered “Vagusstoff” later
  known as acetylcholine
• “father of neuroscience”
• Nobel Prize 1936
Types of Synapses
• Electron Microscope: Beams of electrons are
  presented to a thin section, 50 pm (10-12)
  resolution
Neurotransmitter Criteria
 •   1) Found and made presynaptically.
 •   2) Mechanism for inactivation.
 •   3) Stimulating neuron releases it.
 •   4) Receptors found postsynaptically.
 •   5) Applying substance has biological effect.
 •   6) Antagonizing inhibits biological effect.


“neuromodulators”: don’t meet all criteria 1 to 6
Classical Neurotransmitters
• Amino Acids: GABA, Glutamate
• Monoamines:
  dopamine, norepinephrine, serotonin
• Acetylcholine (ACh)
“Dale’s Principle”
• Old View: Each neuron releases one, and only
  one, neurotransmitter (-ergic)
• New View: neurons typically contain two+
  neurotransmitters (classical & non-classical)
                                        Henry Dale, M.D.




                                           1875-1963
Non-Classical Transmitters
• Peptides: short (<50) strings of amino
  acids, Valine-Glycine-Serine-Alanine… e.g. NPY




                                  C terminal: COOH
                                  N terminal: NH2
                                  Arginine, Proline, Lysine, Phenylalanine,
                                  Methionine, Histidine, Aspartic Acid, Valine
Non-classical Neurotransmitters
• Peptides: Corticotropin-releasing factor
  (CRF), endorphins
• Lipids: Anandamide
• Gases: Nitric Oxide
Neurotransmitter Comparison
                Classical   Non-Classical
Discovery       1950’s      1980’s
Concentration   High        Low
#               Few         Many
Synthesis       Anywhere    Soma
Co-Transmitters
  Amine/Amino Acid                             Peptide
  Dopamine                                     Cholecystokinin (CCK)
  Norepinephrine                               enkephalin
  Epinephrine                                  neurotensin
  Serotonin                                    substance P
  Acetylcholine                                somatostatin
  Gamma aminobutyric acid (GABA)               motilin




Stahl, S. (2000). Essential Psychopharmacology, p. 20.
Axon Terminal
Brakes I: Inactivation of
         Neurotransmitter:
• Enzyme: A + B __ENZ____> AB
• Enzyme: CD    __ENZ____> C + D
Brakes II
• Autoreceptors: this receptor (“auto” = “self”)
  can act to inhibit further neurotransmission
  – Terminal (axon) autoreceptors: inhibit
    neurotransmitter release
  – Somatodendritic autoreceptors: reduce rate of
    action potentials
Brakes III: Transporters
• Proteins that move molecule from one place
  to another, examples:
  – SERT: serotonin transporter
  – NET: norepinephrine transporter
  – DAT: dopamine transporter



                            Inside
                            ----------------------------------------------------------------------
                            Outside
Brakes III: Transporters
• Structure: 12 transmembrane regions
• What happens if you inhibit brakes?
Post-synaptic (Terminology Refresher)
• Ligand: substance that binds to a receptor
• Ion: atom where # electrons ≠ # protons
  – Ca2+ Na+     K+
  – Cl-
• First messenger: neurotransmitter
• Second messenger: other molecule
• Kinase: enzyme that adds phosphate (PO4)
So Many Receptors!
           Serotonin (5-HT):
           1
           2
           3
           4
           5
           6
           7
Family 1: Ionotropic
• Binding to receptor opens channel to let ions
  in (aka: ligand gated ion receptors)
Family 1: Ionotropic
  • Binding to receptor opens channel to let ions
    in (aka: ligand gated ion receptors)




0:40 – 6:20: http://www.youtube.com/watch?v=8jPH2pKzIDY
Allosteric Modulation
• orthosteric: site where the neurotransmitter
  (A) binds to a receptor
• allosteric: site where other molecule (B)
  binds, has no independent effect
Positive Allosteric Modulation

    • A+B>A
    • Example: Benzodiazepines




Stahl (2008). Essentials of Psychopharmacology, p. 144.
Negative Allosteric Modulation

    • A+B<A
    • Example: clozapine




Stahl (2008). Essentials of Psychopharmacology, p. 144.
Family 2: Metabotropic (2nd messenger)
• Steps:
• 1) Ligand binds receptor
• 2) G protein acts on enzyme
• 3) Enzyme regulates 2nd
  messenger
• 4) 2nd messenger acts on
      protein kinase

    6:30-9:00 http://www.youtube.com/watch?v=8jPH2pKzIDY
Family 2: Metabotropic (Channel)
• Steps:
• 1) Ligand binds receptor
• 2) G protein alters
  channel
• 3) ions flow out of
   neuron
Receptor Families Compared
                 Ionotropic                      Metabotropic
                 (nACh, GABA-A, 5-HT3, NMDA)    ( M1, D2, alpha1,2, GABA-B)
Subunits         4-5                            1
Mechanism        Simple: Channel opening        Complex: G protein cascade
2nd messengers   No                             Yes
Speed            Fast (msec)                    Slow (hours – week)




                                               Meyer & Quenzer (2005). p 73
Family 3: Tyrosine Kinase
• Steps:
1) Ligand (BDNF) binds to Trk receptor
2) Trk receptors come together, and
phosphorylate each other
So many potential drug targets!!!



                            Examples:
                            1) Tryptophan
                            6) Nicotine
                            10) MAO-I
                            11) SSRIs
Current Targets of Psychotropic Drugs
  •   Metabotropic Receptors (30%)
  •   Transporters (30%)
  •   Ion Channels (30%)
  •   Enzymes (10%)




Stahl, S. (2008). Essential Psychopharmacology. p. 92.
General Adage
• “every drug acts on at least two receptors, the
  one you know about and the one you don’t”
• Solution:
  – Pharmacological: use selective agonists, problem:
    not available?
  – Knock-out: generate mouse, problem:
    developmental compensation
     • Temporally specific: gene inactivated at specific time
       (adulthood)
     • Tissue specific: gene inactivated in specific region/area

Más contenido relacionado

La actualidad más candente

Synaptic Transmission
Synaptic TransmissionSynaptic Transmission
Synaptic Transmission
vacagodx
 
Physiology of neurotransmitters
Physiology of neurotransmittersPhysiology of neurotransmitters
Physiology of neurotransmitters
Yogesh Ramasamy
 
Intercellular and intracellular cell signaling pathway
Intercellular and intracellular cell signaling pathwayIntercellular and intracellular cell signaling pathway
Intercellular and intracellular cell signaling pathway
SachinGulia12
 

La actualidad más candente (20)

Synaptic transmission
Synaptic transmissionSynaptic transmission
Synaptic transmission
 
Synaptic Transmission
Synaptic TransmissionSynaptic Transmission
Synaptic Transmission
 
Physiology of neurotransmitters
Physiology of neurotransmittersPhysiology of neurotransmitters
Physiology of neurotransmitters
 
Neurotransmitters and their role
Neurotransmitters and their roleNeurotransmitters and their role
Neurotransmitters and their role
 
Neurotransmitter ppt
Neurotransmitter pptNeurotransmitter ppt
Neurotransmitter ppt
 
Synaptic transmission i
Synaptic transmission iSynaptic transmission i
Synaptic transmission i
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Neurotransmitters and its mechanism of action
Neurotransmitters and its mechanism of actionNeurotransmitters and its mechanism of action
Neurotransmitters and its mechanism of action
 
Neurotransmitter
NeurotransmitterNeurotransmitter
Neurotransmitter
 
serotonin/neurotransmitter
serotonin/neurotransmitterserotonin/neurotransmitter
serotonin/neurotransmitter
 
Aminoacid neurotransimitter
Aminoacid neurotransimitterAminoacid neurotransimitter
Aminoacid neurotransimitter
 
Neurotransmitters
Neurotransmitters Neurotransmitters
Neurotransmitters
 
GABA, glutamate receptors and their modulation
GABA, glutamate receptors and their modulationGABA, glutamate receptors and their modulation
GABA, glutamate receptors and their modulation
 
Intercellular and intracellular cell signaling pathway
Intercellular and intracellular cell signaling pathwayIntercellular and intracellular cell signaling pathway
Intercellular and intracellular cell signaling pathway
 
General introduction of neuotransmitters, difference from neuromodulators
General introduction of neuotransmitters, difference from neuromodulatorsGeneral introduction of neuotransmitters, difference from neuromodulators
General introduction of neuotransmitters, difference from neuromodulators
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Glutamate muztaba
Glutamate muztabaGlutamate muztaba
Glutamate muztaba
 
Glutamate receptors
Glutamate receptorsGlutamate receptors
Glutamate receptors
 
L-Glutamate
L-GlutamateL-Glutamate
L-Glutamate
 

Similar a Neurotransmission

Neurotransmission ubc
Neurotransmission ubcNeurotransmission ubc
Neurotransmission ubc
YazeedMD
 
Neurotransmiters of ans synthesis and fate
Neurotransmiters of ans  synthesis and fateNeurotransmiters of ans  synthesis and fate
Neurotransmiters of ans synthesis and fate
Zulcaif Ahmad
 
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
mothersafe
 
Y1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ NeurotransmittersY1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ Neurotransmitters
vajira54
 
An Introduction to Neurotransmitter System
An Introduction to Neurotransmitter SystemAn Introduction to Neurotransmitter System
An Introduction to Neurotransmitter System
Madan Baral
 
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
boscokiuria
 

Similar a Neurotransmission (20)

Neuropharmacology: Neurotransmission
Neuropharmacology: NeurotransmissionNeuropharmacology: Neurotransmission
Neuropharmacology: Neurotransmission
 
Role of Neurotransmitters with their detailed description
Role of Neurotransmitters with their detailed descriptionRole of Neurotransmitters with their detailed description
Role of Neurotransmitters with their detailed description
 
NTs_2.ppt
NTs_2.pptNTs_2.ppt
NTs_2.ppt
 
Nerurons.ppt
Nerurons.pptNerurons.ppt
Nerurons.ppt
 
Neurotransmission ubc
Neurotransmission ubcNeurotransmission ubc
Neurotransmission ubc
 
Signal transmission at synapse
Signal transmission at synapseSignal transmission at synapse
Signal transmission at synapse
 
Neurotransmiters of ans synthesis and fate
Neurotransmiters of ans  synthesis and fateNeurotransmiters of ans  synthesis and fate
Neurotransmiters of ans synthesis and fate
 
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
마더리스크라운드 - Dopamine transporter in ADHD & Alcohol intake
 
Y1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ NeurotransmittersY1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ Neurotransmitters
 
An Introduction to Neurotransmitter System
An Introduction to Neurotransmitter SystemAn Introduction to Neurotransmitter System
An Introduction to Neurotransmitter System
 
Ch 11c
Ch 11cCh 11c
Ch 11c
 
Ch 11c
Ch 11cCh 11c
Ch 11c
 
4 ANS Intro + Cholinergics -41 ff(1).ppt
4 ANS Intro + Cholinergics  -41 ff(1).ppt4 ANS Intro + Cholinergics  -41 ff(1).ppt
4 ANS Intro + Cholinergics -41 ff(1).ppt
 
sensory lect 1.pptx
sensory lect 1.pptxsensory lect 1.pptx
sensory lect 1.pptx
 
CNS.ppt
CNS.pptCNS.ppt
CNS.ppt
 
Autonomic receptors and drugs
Autonomic receptors and drugsAutonomic receptors and drugs
Autonomic receptors and drugs
 
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
97308319-Neurotransmitter-and-Its-Synapses-Ppt.pdf
 
Nerve transmission
Nerve transmissionNerve transmission
Nerve transmission
 
Nerve transmission
Nerve transmissionNerve transmission
Nerve transmission
 
ANS pharmacology ppt
ANS pharmacology pptANS pharmacology ppt
ANS pharmacology ppt
 

Más de Brian Piper

Más de Brian Piper (20)

Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
 
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part II
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part I
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for Bipolar
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSD
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SAD
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part II
 
Antipsychotics I
Antipsychotics IAntipsychotics I
Antipsychotics I
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNS
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part I
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part II
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part I
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
 
ADHD Drugs
ADHD DrugsADHD Drugs
ADHD Drugs
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
 

Neurotransmission

  • 2. Goals • Introduction to neurocommunication • Families of receptors (2) • Inactivation of neurotransmission (3)
  • 3. Otto Loewi • Discovered “Vagusstoff” later known as acetylcholine • “father of neuroscience” • Nobel Prize 1936
  • 4.
  • 5. Types of Synapses • Electron Microscope: Beams of electrons are presented to a thin section, 50 pm (10-12) resolution
  • 6.
  • 7. Neurotransmitter Criteria • 1) Found and made presynaptically. • 2) Mechanism for inactivation. • 3) Stimulating neuron releases it. • 4) Receptors found postsynaptically. • 5) Applying substance has biological effect. • 6) Antagonizing inhibits biological effect. “neuromodulators”: don’t meet all criteria 1 to 6
  • 8. Classical Neurotransmitters • Amino Acids: GABA, Glutamate • Monoamines: dopamine, norepinephrine, serotonin • Acetylcholine (ACh)
  • 9. “Dale’s Principle” • Old View: Each neuron releases one, and only one, neurotransmitter (-ergic) • New View: neurons typically contain two+ neurotransmitters (classical & non-classical) Henry Dale, M.D. 1875-1963
  • 10. Non-Classical Transmitters • Peptides: short (<50) strings of amino acids, Valine-Glycine-Serine-Alanine… e.g. NPY C terminal: COOH N terminal: NH2 Arginine, Proline, Lysine, Phenylalanine, Methionine, Histidine, Aspartic Acid, Valine
  • 11. Non-classical Neurotransmitters • Peptides: Corticotropin-releasing factor (CRF), endorphins • Lipids: Anandamide • Gases: Nitric Oxide
  • 12. Neurotransmitter Comparison Classical Non-Classical Discovery 1950’s 1980’s Concentration High Low # Few Many Synthesis Anywhere Soma
  • 13. Co-Transmitters Amine/Amino Acid Peptide Dopamine Cholecystokinin (CCK) Norepinephrine enkephalin Epinephrine neurotensin Serotonin substance P Acetylcholine somatostatin Gamma aminobutyric acid (GABA) motilin Stahl, S. (2000). Essential Psychopharmacology, p. 20.
  • 15. Brakes I: Inactivation of Neurotransmitter: • Enzyme: A + B __ENZ____> AB • Enzyme: CD __ENZ____> C + D
  • 16. Brakes II • Autoreceptors: this receptor (“auto” = “self”) can act to inhibit further neurotransmission – Terminal (axon) autoreceptors: inhibit neurotransmitter release – Somatodendritic autoreceptors: reduce rate of action potentials
  • 17. Brakes III: Transporters • Proteins that move molecule from one place to another, examples: – SERT: serotonin transporter – NET: norepinephrine transporter – DAT: dopamine transporter Inside ---------------------------------------------------------------------- Outside
  • 18. Brakes III: Transporters • Structure: 12 transmembrane regions • What happens if you inhibit brakes?
  • 19.
  • 20. Post-synaptic (Terminology Refresher) • Ligand: substance that binds to a receptor • Ion: atom where # electrons ≠ # protons – Ca2+ Na+ K+ – Cl- • First messenger: neurotransmitter • Second messenger: other molecule • Kinase: enzyme that adds phosphate (PO4)
  • 21. So Many Receptors! Serotonin (5-HT): 1 2 3 4 5 6 7
  • 22. Family 1: Ionotropic • Binding to receptor opens channel to let ions in (aka: ligand gated ion receptors)
  • 23. Family 1: Ionotropic • Binding to receptor opens channel to let ions in (aka: ligand gated ion receptors) 0:40 – 6:20: http://www.youtube.com/watch?v=8jPH2pKzIDY
  • 24. Allosteric Modulation • orthosteric: site where the neurotransmitter (A) binds to a receptor • allosteric: site where other molecule (B) binds, has no independent effect
  • 25. Positive Allosteric Modulation • A+B>A • Example: Benzodiazepines Stahl (2008). Essentials of Psychopharmacology, p. 144.
  • 26. Negative Allosteric Modulation • A+B<A • Example: clozapine Stahl (2008). Essentials of Psychopharmacology, p. 144.
  • 27. Family 2: Metabotropic (2nd messenger) • Steps: • 1) Ligand binds receptor • 2) G protein acts on enzyme • 3) Enzyme regulates 2nd messenger • 4) 2nd messenger acts on protein kinase 6:30-9:00 http://www.youtube.com/watch?v=8jPH2pKzIDY
  • 28. Family 2: Metabotropic (Channel) • Steps: • 1) Ligand binds receptor • 2) G protein alters channel • 3) ions flow out of neuron
  • 29. Receptor Families Compared Ionotropic Metabotropic (nACh, GABA-A, 5-HT3, NMDA) ( M1, D2, alpha1,2, GABA-B) Subunits 4-5 1 Mechanism Simple: Channel opening Complex: G protein cascade 2nd messengers No Yes Speed Fast (msec) Slow (hours – week) Meyer & Quenzer (2005). p 73
  • 30. Family 3: Tyrosine Kinase • Steps: 1) Ligand (BDNF) binds to Trk receptor 2) Trk receptors come together, and phosphorylate each other
  • 31.
  • 32. So many potential drug targets!!! Examples: 1) Tryptophan 6) Nicotine 10) MAO-I 11) SSRIs
  • 33. Current Targets of Psychotropic Drugs • Metabotropic Receptors (30%) • Transporters (30%) • Ion Channels (30%) • Enzymes (10%) Stahl, S. (2008). Essential Psychopharmacology. p. 92.
  • 34. General Adage • “every drug acts on at least two receptors, the one you know about and the one you don’t” • Solution: – Pharmacological: use selective agonists, problem: not available? – Knock-out: generate mouse, problem: developmental compensation • Temporally specific: gene inactivated at specific time (adulthood) • Tissue specific: gene inactivated in specific region/area